Plain-English translation of NCT07402707 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing dexamethasone, a steroid medication that doctors give to children who come to the emergency department with severe asthma attacks. The study is comparing two different doses to see if both work equally well at stopping the attack and helping children breathe easier. Right now, different hospitals use different amounts of this medication, so researchers want to figure out which dose is best.
Many children arrive at emergency departments with asthma attacks that need urgent treatment with steroids. The medication works well, but doctors aren't sure if the standard high dose is necessary or if a lower dose would work just as well—which could mean fewer side effects and simpler treatment for children.
You likely qualify if…
You likely don't qualify if…
If your child is chosen for this trial, they will receive a single dose of the steroid medication while you are in the emergency department—either the lower or higher dose, decided by chance. The medication replaces what would normally be given anyway for an asthma attack, so there's no extra treatment involved. The doctors will monitor your child's response to see how well the medication works.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United Kingdom